A Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, Safety and Pharmacokinetic Study of Single Doses of DFN-15 in Post-Surgical Dental Pain
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 Feb 2019
At a glance
- Drugs Celecoxib (Primary)
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 04 Feb 2019 Planned End Date changed from 1 Dec 2018 to 1 Apr 2019.
- 04 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 20 Jun 2018 Status changed from not yet recruiting to recruiting.